NOTE (NOTE) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
2 Feb, 2026Executive summary
Achieved record Q4 profitability and operating margin, reaching the upper end of long-term objectives, despite market softness and defense sector delays.
Q4 sales exceeded SEK 1 billion, with full-year sales at SEK 3.8 billion, reflecting stable performance.
Demonstrated adaptability amid market challenges, with sales just meeting guidance due to temporary Defence segment delays.
Order backlog reached its highest ever, especially in Defence, supporting a positive outlook for 2026 and beyond.
Major expansion of the Torsby plant in Sweden doubled production capacity, supporting future growth.
Financial highlights
Q4 net sales: SEK 1,001 million; full-year net sales: SEK 3,814 million.
Q4 operating profit: SEK 113 million; adjusted operating profit: SEK 114 million.
Underlying operating profit margin was 11.4% for Q4, the highest ever, and 10.1% for the year.
Operating cash flow was the weakest in nine quarters due to delayed customer payments, but these have since been resolved.
Net debt increased to SEK 403 million after acquisitions, with equity ratio at nearly 50%.
Outlook and guidance
Defence segment expected to deliver strong growth, with a +30% year-over-year target until 2030, supported by a robust order backlog.
Defense sector challenges expected to persist into early 2026, with gradual improvement anticipated later in the year.
No dividend proposed for 2025 to maintain financial flexibility amid sector transformation.
Expects at least one acquisition in 2026, supported by a strong balance sheet.
CapEx investments for 2026 projected at SEK 100–125 million for equipment, plus SEK 20 million for buildings.
Latest events from NOTE
- Sales and profit fell, but margins and cash flow improved as investments support future growth.NOTE
Q2 20243 Feb 2026 - Sales fell 22% in Q3, but strong cash flow and expansion plans support future growth.NOTE
Q3 202419 Jan 2026 - Double-digit profitability and stable growth expected, with defense and medtech leading future gains.NOTE
CMD 202411 Jan 2026 - Margins and cash flow improved as sales declined, supporting a positive 2025 outlook.NOTE
Q4 20249 Jan 2026 - Profitability and cash flow hit highs, with Security & Defence and Greentech driving growth.NOTE
Q1 202523 Dec 2025 - Strong Q2 sales and cash flow, with H2 growth expected despite FX and market headwinds.NOTE
Q2 202516 Nov 2025 - Q3 2025 saw strong growth, profitability, and a strategic UK acquisition for future expansion.NOTE
Q3 202520 Oct 2025